Cubist Pharmaceuticals has opened its expanded facility for research and development, which is situated at Lexington in Massachusetts. The 104000 square-foot extended building has a sophisticated laboratory for antibiotics research and development. In addition, research for acute care products will be carried out in the laboratory.
"Senator Scott Brown with Cubist Pharmaceutical President and CEO Michael Bonney cut the ribbon marking the official opening of the company's expanded research facility in Lexington, Massachusetts."
Furthermore, the building has a room for molecular designing, conference rooms and office space. The LEED Silver Standard building includes superior lighting fixtures and plumbing, modernized mechanical instruments, energy star-rated equipments and distribution controlled heating and cooling systems.
An official opening ceremony was held at the expanded R&D building situated in the company’s headquarters. Scott Brown, the U.S. Senator was the special guest for the ceremony.
Michael Bonney, the CEO and President of the company stated that the R&D facility will support the growth and innovative development of the company in future. He added that the company is looking forward to converting amazing scientific theories to realistic acute care treatment options.
Scott Brown stated that companies such as Cubist Pharmaceuticals create job opportunities in Massachusetts and added that he will support companies like Cubist in the Senate for creating more jobs in the city.
The company specializes in research and development and marketing of biopharmaceutical products, which includes acute care products for patients.
Source: https://www.merck.com/